TNBC no longer active?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

TNBC no longer active?

posted on Jun 27, 2023 05:05PM

Previously (last year?), Don said that Zenith has 2 potentially registration-enabling trials ongoing (See slide 5 here)

1. TNBC; presumably NCT03901469 (phase 2, recruiting, 179 patients)

2. mCRPC; presumably NCT04986423 (phase 2, recruiting, 200 patients)

The RVX AGM - at 31:00 - Don says Zenith is no longer pursuing TNBC because someone else got there first.

I think this was pretty bad news. He kind of off-the-cuff "oh, yeah, this happened".